Toxidromes Crash Course: Symptoms, Mnemonics, and Acute Care Essentials

Decontamination methods include inducing vomiting, gastric lavage, activated charcoal, laxatives, and whole bowel irrigation. Activated charcoal (1g/kg) is most effective for most toxins, more so than gastric lavage, and can be administered sooner. Gastric lavage is indicated only for potent toxins (tricyclics, opioids, salicylates) within 1 hour, but carries risks of aspiration, nasal trauma, arrhythmias, and may increase absorption by pushing toxin into intestine. Contraindications include caustics, hydrocarbons, and altered mental status. Laxatives are discouraged as they don't reduce mortality/hospital stay and worsen electrolytes. Whole bowel irrigation is reserved for drug packet ingestions. Advanced elimination techniques include intralipid emulsion therapy (20% lipid emulsion, bolus 1.5ml/kg, maintenance 0.25ml/kg/h) for lipophilic toxins like local anesthetics, tricyclics, calcium channel blockers, and beta-blockers. Forced diuresis is no longer recommended due to electrolyte disturbances and renal risk. Urinary alkalinization (bicarbonate 1-2mg/kg IV q3-4h, maintaining pH 7.6-8) helps dissociate toxins from albumin for barbiturates, tricyclics, and salicylates.

External decontamination requires immediate flushing for eye exposures (until pH normalizes) and thorough skin rinsing with water. GI decontamination is most effective within the first hour post-ingestion. Gastric lavage is reserved for massive life-threatening ingestions. Whole bowel irrigation with polyethylene glycol is used for sustained-release pills and substances charcoal doesn't bind. Activated charcoal works through enormous surface area but fails for heavy metals, alcohols, and corrosives. Urinary alkalinization enhances elimination of weak acids like salicylates through ion trapping. Multiple dose activated charcoal maintains gut concentration gradients and blocks enterohepatic recirculation but requires confirming bowel sounds before each dose.

Gastrointestinal decontamination methods include induced vomiting, activated charcoal, cathartics, and gastric lavage. Induced vomiting is contraindicated in patients with low consciousness (aspiration risk), corrosive ingestions (re-injury), petroleum derivatives (chemical pneumonitis), and in children/pregnant women. Activated charcoal acts as a chemical sponge binding toxins in the GI tract, often used with cathartics (sodium sulfate, magnesium sulfate, mannitol) to accelerate transit. Gastric lavage is most effective within the first hour post-ingestion, using left lateral decubitus positioning to prevent aspiration. These methods can be combined based on clinical judgment, timing, and toxin type.

Toxic exposures occur through inhalation, absorption, injection, or ingestion. First step is interrupting persistent exposure and washing eyes/skin with water. GI decontamination prevents absorption after ingestion through gastric emptying, adsorption, and catharsis. Minimum indications: potentially dangerous substance, unabsorbed in GI tract, and safe procedure. Gastric emptying can be induced by ipecac syrup (15-30 mL oral dose) or lavage. Ipecac acts as local irritant and central effect on chemoreceptor trigger zone, producing vomiting in 15-30 minutes. Contraindications include CNS depression, corrosive/hydrocarbon ingestion, conditions exacerbated by vomiting, and bulimia. Ipecac can cause electrolyte abnormalities, ventricular arrhythmias, and death. Gastric lavage uses 24-40F tube in left lateral decubitus position, administering 10-15 mL/kg saline until output is clear. Activated charcoal is the most frequently used adsorbent, recommended dose 0.5-1 g/kg up to 75-100 g maximum. Efficacy decreases with time; ineffective for alcohols, corrosives, hydrocarbons, and metals. Whole bowel irrigation uses isotonic electrolyte solution with polyethylene glycol at 25-40 mL/kg/hour until rectal output is clear. Indications include drug packets, iron overdose, transdermal patches, and extended-release drug overdose. Contraindicated in intestinal obstruction or perforation. Methods to enhance elimination include urinary alkalinization (for weak acids like salicylates, phenobarbital, methotrexate), multiple-dose activated charcoal (interrupting enterohepatic circulation), and extracorporeal elimination (hemodialysis for salicylates, methanol, ethylene glycol, lithium, carbamazepine, valproic acid). Antidotal treatment involves receptor competition (naloxone for heroin), physiological mechanisms (glucagon for propranolol), or interrupting toxic metabolite formation (fomepizole for ethylene glycol/methanol).

This segment covers gastrointestinal decontamination and advanced elimination methods. Activated charcoal works by adsorption, binding toxic substances in the GI tract. Efficacy decreases with time: 73% reduction in absorption within 30 minutes, 51% at 30 minutes, and 37% at 60 minutes. Multiple-dose charcoal (max 4 doses of 200g each, every 4 hours) is used for carbamazepine, digoxin, and phenytoin. Contraindications include depressed consciousness without airway protection, corrosive/hydrocarbon ingestion, GI hemorrhage risk, and recent abdominal surgery. Gastric lavage is indicated within 1 hour of ingestion for potentially toxic substances, massive ingestion, or when no antidote exists. Efficacy decreases to 8-32% recovery at 60 minutes. Extracorporeal methods (hemodialysis, hemoperfusion, plasma exchange) accelerate removal of dialyzable substances including salicylates, lithium, methanol, ethylene glycol, and phenytoin. Valproic acid is poorly dialyzable.

Four toxidromes present similarly: serotonin syndrome, neuroleptic malignant syndrome, anticholinergic toxicity, and malignant hyperthermia. Differentiation criteria: onset timing (serotonin syndrome is rapid; malignant hyperthermia is within minutes of volatile anesthetic/succinylcholine), muscle tone (serotonin syndrome shows hyperreflexia/clonus; neuroleptic malignant syndrome shows lead-pipe rigidity; anticholinergic toxicity shows normal reflexes), mental status (serotonin syndrome shows agitation/delirium; malignant hyperthermia shows stupor/coma; anticholinergic shows delirium/hallucinations), skin findings (serotonin syndrome/dry skin show diaphoresis; anticholinergic shows dry skin), and response to benzodiazepines (serotonin syndrome improves; others do not). CK elevation helps differentiate severity.

Serotonin syndrome presents with dilated pupils, agitation, confusion, hyperthermia, tachycardia, sweating, and hyperreflexia (remembered as 'head red and dead'). Mortality rate is 2-12% if untreated. Anticholinergic toxicity presents with dilated pupils, hot, red, tachycardia, confusion, dry mouth, urinary retention, and visual disturbances. Both syndromes present similarly and require medication review for differentiation. These are red flag side effects requiring immediate medical intervention.

Serotonin syndrome must be differentiated from several conditions: (1) Malignant hyperthermia (family history, halogenated anesthetics/succinylcholine exposure, temperature >41°C, rapid temp rise >1°C/30 min, muscle rigidity, cyanosis, hypoxemia, hypercarbia, metabolic acidosis, hyperkalemia, arrhythmia); (2) Anticholinergic syndrome (anticholinergic drugs, agitation, hallucination, delirium, mydriasis, tachycardia, hypertension, dry mucous membranes, decreased bowel sounds); (3) Opioid toxicity (meiosis, hypothermia, respiratory depression, hyporeflexia, pinpoint pupils, bradycardia, pale skin); (4) Neuroleptic malignant syndrome (gradual onset, lead-pipe rigidity, fever, dysautonomia, no GI symptoms); (5) Delirium (acute onset, inattention, disorganized thinking, altered arousal, no neuromuscular activation).

Four syndromes require differential diagnosis: Serotonin Syndrome (rapid onset, dilated pupils, hyperreflexia, hyperexcitation), Neuroleptic Malignant Syndrome (slower onset, normal pupils, rigidity, stupor/coma), Anticholinergic Toxicity (dry hyperthermia, dilated pupils, decreased motility), and Malignant Hyperthermia (most rapid, triggered by anesthetics). Key differentiating features include onset speed, pupil size, sweating status, muscle tone, reflexes, and patient consciousness. All except Anticholinergic Toxicity share hypertension, tachycardia, tachypnea, and hyperthermia.

Four major toxidromes present with overlapping symptoms including tachycardia, diaphoresis, hypertension, fever, and pupil dilation. Sympathomimetic toxidrome (cocaine/meth) activates the sympathetic nervous system. Anticholinergic toxidrome blocks acetylcholine, causing dry skin instead of sweating. Neuroleptic malignant syndrome (antipsychotics) causes muscle rigidity and bradycardia. Serotonin syndrome (antidepressants) causes neuromuscular hyperreactivity with hyperreflexia, tremors, and myoclonus. Differentiation relies on neuromuscular characteristics: rigidity vs. hyperactivity, and the presence of clonus.

The osmolar gap helps identify toxic alcohol ingestion when metabolic acidosis is present. It is calculated as: Measured Osmolality - Calculated Osmolality, where Calculated Osmolality = 2×Sodium + Glucose/18 + BUN/2.8. A normal osmolar gap is less than 10 mOsm/kg. An elevated osmolar gap suggests methanol, ethylene glycol, or isopropyl alcohol ingestion. These substances can be measured directly, and treatment with antidotes (fomepizole, ethanol) is essential. The urine anion gap helps distinguish renal from gastrointestinal causes of non-anion gap metabolic acidosis. Urine Anion Gap = Urine Sodium + Urine Potassium - Urine Chloride. A positive urine anion gap indicates renal tubular acidosis (kidney cannot excrete acid). A negative urine anion gap indicates gastrointestinal bicarbonate loss.

Laboratory evaluation focuses on identifying metabolic acidosis through anion gap (AG = Na+ - [Cl- + HCO3-]; elevated AG suggests organic acids like methanol, ethylene glycol, salicylates) and osmolar gap (measured vs calculated osmolality; elevated indicates alcohols, methanol, contrast agents). Oxygen saturation discrepancy (>5%) suggests carbon monoxide, methemoglobinemia, or cyanide poisoning. Toxicological screening identifies specific toxins for antidote administration but modifies management in only ~5% of cases. Rapid urine tests detect drugs of abuse; serum testing quantifies ethanol, methanol, salicylates, lithium, and anticonvulsants. Results may not be available quickly enough for acute management decisions.

This section covers advanced ABG interpretation techniques for complex clinical scenarios. Anion gap calculation (Na+ + K+) - (Cl- + HCO3-), normal 12 ± 4 mEq/L, distinguishes high anion gap metabolic acidosis (DKA, lactic acidosis, uremia) from normal anion gap causes (diarrhea, renal tubular acidosis). Osmolar gap >10 mOsm/kg suggests toxic alcohol ingestion. Clinical case analysis demonstrates how to identify mixed disorders: a patient with pH 7.2, CO2 32, and bicarbonate 18 has metabolic acidosis with concurrent respiratory acidosis (inadequate compensation). A post-cardiac arrest patient with pH 6.8, CO2 82, and bicarbonate 14 has severe metabolic acidosis with respiratory acidosis. These cases illustrate the importance of systematic analysis in critical care settings.

Anion gap (AG = [Na+] - ([Cl-] + [HCO3-]), expected 10 ± 2) categorizes metabolic acidosis: high AG (>12) indicates unmeasured anion accumulation (MUDPILES: Methanol, Uremia, DKA, Paraldehyde, Lactic acidosis, Ethylene glycol, Salicylates, Toxins); normal AG indicates bicarbonate loss with chloride increase (diarrhea, RTA, saline infusion). The osmolar gap (calculated vs. measured osmolarity, expected 285 ± 10) detects low-molecular-weight toxins like methanol, ethylene glycol, or ethanol by identifying disparities between measured and calculated values.

This section demonstrates step-by-step calculation of the osmolar gap using clinical examples. The key insight is that the osmolar gap doesn't represent a real physiological gap but rather an accounting gap in our calculation method—the formula excludes many substances. The mnemonic METH (methanol, ethanol, isopropanol) and PROP (propylene glycol, ethylene glycol) plus sugars (sorbitol, mannitol) helps memorize substances that increase the gap. Three substances (methanol, ethylene glycol, propylene glycol) uniquely affect both the osmolar gap and anion gap.